Related references
Note: Only part of the references are listed.Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis: An Open-Label, Randomized Controlled Trial of Lactulose, Probiotics, and No Therapy
Amit Agrawal et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials
Jelena Savovic et al.
ANNALS OF INTERNAL MEDICINE (2012)
Theories of the Pathogenesis of Hepatic Encephalopathy
E. Anthony Jones et al.
CLINICS IN LIVER DISEASE (2012)
Hepatic Encephalopathy and Health-Related Quality of Life
Giampaolo Bianchi et al.
CLINICS IN LIVER DISEASE (2012)
Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: An open labeled randomized controlled trial of lactulose versus no lactulose
Praveen Sharma et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study
A. Sanyal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Rifaximin Improves Psychometric Performance and Health-Related Quality of Life in Patients With Minimal Hepatic Encephalopathy (The RIME Trial)
Sandeep Singh Sidhu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Effects of Branched-Chain Amino Acids Supplementation in Patients With Cirrhosis and a Previous Episode of Hepatic Encephalopathy: A Randomized Study
Inigo Les et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
The Multi-Dimensional Burden of Cirrhosis and Hepatic Encephalopathy on Patients and Caregivers
Jasmohan S. Bajaj et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy
Vibhu Vibhas Mittal et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2011)
Rifaximin Treatment in Hepatic Encephalopathy
Nathan M. Bass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Secondary Prophylaxis of Hepatic Encephalopathy: An Open-Label Randomized Controlled Trial of Lactulose Versus Placebo
Barjesh Chander Sharma et al.
GASTROENTEROLOGY (2009)
Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines
Christopher Randolph et al.
LIVER INTERNATIONAL (2009)
Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy
Srinivasa Prasad et al.
HEPATOLOGY (2007)
Review article: the burden of hepatic encephalopathy
F. F. Poordad
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis
Y Muto et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials
B Als-Nielsen et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: A double-blind, randomized trial
G Marchesini et al.
GASTROENTEROLOGY (2003)
Ammonia, the GABA neurotransmitter system, and hepatic encephalopathy
EA Jones
METABOLIC BRAIN DISEASE (2002)
Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998
P Ferenci et al.
HEPATOLOGY (2002)
Share Paper
